secwatch.observer — SEC 8-K summary
======================================

Issuer:     Avantor, Inc. (AVTR)
CIK:        0001722482
Form:       8-K
Filed at:   2024-02-14T23:59:59+00:00
Accession:  0001722482-24-000014
Event type: earnings
Sentiment:  neutral
Materiality: 0.80
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Avantor Q4 revenue $1.72B, decline 4%; adjusted EPS $0.25; new segment structure disclosed
--------------------------------------------------------------------------------

- Q4 net sales $1.72B, down 4.0% YoY; core organic decline 4.8%; Q4 GAAP EPS $0.15, adjusted EPS $0.25.
- Full-year 2023 net sales $6.97B, down 7.3%; adjusted EBITDA $1.309B; free cash flow $723.6M.
- Repaid ~$850M of debt in 2023; adjusted net leverage 3.9x.
- New segment reporting effective Q1 2024: Laboratory Solutions ($4.74B revenue in 2023) and Bioscience Production ($2.23B revenue).
- Recast segment data provided for 2021-2023; adjusted operating income for Bioscience Production $601.9M, Laboratory Solutions $668.3M in 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1722482/000172248224000014/0001722482-24-000014-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1722482/000172248224000014/avtr-20240214.htm
  HTML page:      https://secwatch.observer/filing/0001722482-24-000014

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer